Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Chemomab Therapeutics Ltd. CMMB

Full chart Compare
Set alert

Price alert · CMMB

All alert types
1.18 USD 0.00 (+0.00%)

At closeNov 3, 2026, 4:00 PM EST

1.35 +0.17 +14.41%

After hours · Nov 3, 4:00 PM ET

1.16 Day range 1.33
0.92 52-week range 2.99
YTD
-28.48%
1 year
-57.86%

Financial health

Altman Z-Score

-14.08 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

0 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C+2 / 5 overall

  • DCF 4
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 4

Valuation

P/E -1.2×
FY 2016: -10.0×FY 2017: -0.8×FY 2018: -7.9×FY 2019: -1.4×FY 2020: -0.2×FY 2021: -5.8×FY 2022: -1.3×FY 2023: -0.2×FY 2024: -0.1×FY 2025: -1.2×
FY 2016 5y median -1.2× FY 2025
P/S 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
P/B 0.9×
FY 2016: 14.3×FY 2017: -12.8×FY 2018: 11.1×FY 2019: 3.1×FY 2020: 0.2×FY 2021: 1.2×FY 2022: 1.0×FY 2023: 0.4×FY 2024: 0.1×FY 2025: 0.9×
FY 2016 5y median 0.9× FY 2025
P/FCF -0.9×
FY 2016: -12.3×FY 2017: -0.9×FY 2018: -7.6×FY 2019: -2.3×FY 2020: -0.2×FY 2021: -5.7×FY 2022: -1.8×FY 2023: -0.3×FY 2024: -0.1×FY 2025: -0.9×
FY 2016 5y median -0.9× FY 2025
EV/EBITDA -0.3×
FY 2016: -9.3×FY 2017: -0.7×FY 2018: -7.6×FY 2019: -0.8×FY 2020: 0.8×FY 2021: -4.6×FY 2022: -0.8×FY 2023: 0.1×FY 2024: 0.3×FY 2025: -0.3×
FY 2016 5y median -0.3× FY 2025
EV/Sales 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
FCF Yield -106.6%
FY 2016: -8.1%FY 2017: -110.5%FY 2018: -13.2%FY 2019: -43.0%FY 2020: -500.0%FY 2021: -17.6%FY 2022: -55.9%FY 2023: -393.0%FY 2024: -1052.3%FY 2025: -106.6%
FY 2016 5y median -106.6% FY 2025

Profitability

Gross Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
ROE -72.9%
FY 2016: -143.7%FY 2017: 1610.2%FY 2018: -140.7%FY 2019: -219.9%FY 2020: -108.2%FY 2021: -20.3%FY 2022: -76.3%FY 2023: -142.5%FY 2024: -103.0%FY 2025: -72.9%
FY 2016 5y median -76.3% FY 2025
ROIC -77.6%
FY 2016: -140.7%FY 2017: 1542.2%FY 2018: -130.2%FY 2019: -121.7%FY 2020: -96.8%FY 2021: -20.0%FY 2022: -76.8%FY 2023: -146.4%FY 2024: -106.3%FY 2025: -77.6%
FY 2016 5y median -77.6% FY 2025
ROA -65.1%
FY 2016: -83.8%FY 2017: -469.9%FY 2018: -108.1%FY 2019: -137.7%FY 2020: -93.7%FY 2021: -19.4%FY 2022: -64.2%FY 2023: -109.3%FY 2024: -82.2%FY 2025: -65.1%
FY 2016 5y median -65.1% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 FY 2025
Operating Income 35.1%
FY 2016: 35.0%FY 2017: -102.7%FY 2018: -38.8%FY 2019: -50.4%FY 2020: 43.7%FY 2021: -12.1%FY 2022: -130.6%FY 2023: 10.8%FY 2024: 42.1%FY 2025: 35.1%
FY 2016 FY 2025
EPS (diluted) 97.9%
FY 2016: 47.6%FY 2017: -1169.5%FY 2018: 90.1%FY 2019: 27.4%FY 2020: -697.8%FY 2021: 99.0%FY 2022: -101.7%FY 2023: 15.0%FY 2024: -736.5%FY 2025: 97.9%
FY 2016 FY 2025
Free Cash Flow 27.4%
FY 2016: 49.0%FY 2017: -126.0%FY 2018: -67.0%FY 2019: -15.4%FY 2020: 22.7%FY 2021: 1.7%FY 2022: -61.3%FY 2023: -15.7%FY 2024: 34.4%FY 2025: 27.4%
FY 2016 FY 2025

Financial Health

Current Ratio 9.1×
FY 2016: 2.1×FY 2017: 0.6×FY 2018: 4.0×FY 2019: 4.4×FY 2020: 9.0×FY 2021: 23.7×FY 2022: 6.2×FY 2023: 4.3×FY 2024: 5.0×FY 2025: 9.1×
FY 2016 5y median 6.2× FY 2025
Quick Ratio 9.1×
FY 2016: 2.1×FY 2017: 0.6×FY 2018: 4.0×FY 2019: 4.4×FY 2020: 9.0×FY 2021: 23.7×FY 2022: 6.2×FY 2023: 4.3×FY 2024: 5.0×FY 2025: 9.1×
FY 2016 5y median 6.2× FY 2025
Debt / Equity 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.1×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA 0.8×
FY 2016: 1.0×FY 2017: 0.2×FY 2018: 0.6×FY 2019: 0.6×FY 2020: 1.0×FY 2021: 1.2×FY 2022: 0.5×FY 2023: 0.4×FY 2024: 0.4×FY 2025: 0.8×
FY 2016 5y median 0.5× FY 2025
Interest Coverage 0.0×
FY 2016: 0.0×FY 2017: -1878×FY 2018: 0.0×FY 2019: -2179×FY 2020: -1827×FY 2021: -111×FY 2022: -80.8×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31